Daily Vitamin C Tablets: What the Evidence Shows

A daily vitamin C tablet clearly helps people who fall short on food, and gives modest, specific gains to a few others; it does not reliably prevent colds, heart disease or cancer in well-nourished adults.

Evidence at a glance

The strength ratings below are this article’s own summary of the sources linked in each row.

Claimed benefit Evidence strength What the research found
Preventing deficiency (scurvy) Strong Signs can appear within a month at under about 10 mg a day; smokers can have greater vitamin C needs (NIH ODS; Australian NRVs)
Shorter, milder colds Moderate Regular use trimmed cold duration about 8% in adults and 14% in children (Cochrane)
Fewer colds Narrow Incidence halved only in marathon runners, skiers and soldiers; no effect in the general population (Cochrane)
Better iron absorption Moderate for single meals About 5.9 percentage points more nonheme iron absorbed per meal (Heffernan, Proc Nutr Soc)
Lower blood pressure Moderate, short-term Systolic fell about 3.8 mm Hg across 29 trials (Am J Clin Nutr 2012)
Fewer heart attacks and strokes Not supported No effect on major events in 14,641 men over 8 years (PHS II, JAMA)
Skin health and collagen Limited Essential for collagen; trials of oral tablets are thin (Nutrients 2017)
Slower macular degeneration Moderate, as part of a formula 28% lower progression to advanced disease with the AREDS combination (NIH ODS)
Lower uric acid and gout Modest Urate fell in a meta-analysis of trials; modest fall in new gout diagnoses (PHS II gout)
Cancer prevention Not supported Most randomized trials show no effect (NIH ODS)

The pattern is consistent: gains are largest where intake is low, and shrink toward zero once body stores are full.

What vitamin C does in the body

Vitamin C (L-ascorbic acid) is a water-soluble vitamin that humans cannot make, so every bit of it comes from food or supplements. The NIH Office of Dietary Supplements lists its core jobs: it is required to build collagen, L-carnitine and certain neurotransmitters, it works as an antioxidant that regenerates vitamin E, it supports immune function, and it improves absorption of nonheme (plant) iron.

How much vitamin C do you need? Australian vs US guidelines

Vitamin C recommendations differ between Australia and the United States. The figures below are recommended daily dietary intakes, not suggested tablet strengths. The Australian recommendations are called RDIs (recommended dietary intakes); the US recommendations are RDAs (recommended dietary allowances).

Life stage (19 years and older) Australia (RDI) United States (RDA)
Men 45 mg/day 90 mg/day
Women 45 mg/day 75 mg/day
Pregnancy 60 mg/day 85 mg/day
Breastfeeding 85 mg/day 120 mg/day
People who smoke No separate additional RDI is specified Add 35 mg/day to the relevant US RDA

The Australian Nutrient Reference Values account for smokers when establishing the adult estimate and do not prescribe a separate 35 mg increase. The US NIH explicitly recommends that additional amount for smokers. Smoking can lower vitamin C status in either country; the difference is between the guidance systems, not the underlying biology.

Sources: Australian and New Zealand Nutrient Reference Values — Vitamin C; NIH Office of Dietary Supplements — Vitamin C (Health Professional).

Neither country’s daily intake figure means that everyone should take a vitamin C tablet. A varied diet can meet requirements for many people, and a supplement is most relevant when food intake is inadequate or a clinician identifies a specific reason for it.

Where it comes from. Fruit and vegetables supply most of it: half a cup of raw red pepper has 95 mg, one medium orange 70 mg and one kiwifruit 64 mg. Five varied servings a day can provide more than 200 mg. The ascorbic acid in tablets is as bioavailable as the form found in orange juice or broccoli (NIH ODS).

Deficiency. Scurvy can appear within about a month of eating under roughly 10 mg a day. Early signs are fatigue, malaise and inflamed gums, followed by easy bruising, joint pain, poor wound healing and loosening teeth, because collagen can no longer be made properly. It is rare in developed countries, but a low intake (below locally recommended levels but above the amount generally associated with scurvy) is more likely in:

  • People who smoke or are exposed to secondhand smoke
  • People with a very limited variety of foods, including some older adults living alone and people with heavy alcohol or drug use
  • People with intestinal malabsorption, some cancer patients and people on long-term hemodialysis This is the group where a daily tablet has the clearest justification, and it frames everything that follows: most research benefits are strongest when starting levels are low.

Colds and immune function

Why it plausibly helps. A 2017 review in Nutrients by Carr and Maggini found that vitamin C supports the skin and epithelial barrier against pathogens and accumulates in phagocytes such as neutrophils. In those cells it can enhance movement toward infection, engulfing of microbes, and microbial killing. Deficiency, in turn, impairs immunity and raises susceptibility to infection.

The same review’s summary table carries an important caveat: many of the underlying studies began with marginal or deficient vitamin C status, and supplementing someone who is already replete may not have comparable effects.

What the Cochrane review found. The most cited test is the Cochrane review of placebo-controlled trials, in its 2013 edition. Its findings split three ways:

  • Preventing colds in the general population: no effect across 29 trials with 11,306 participants, according to a summary of the review.
  • Preventing colds under extreme stress: in five trials of 598 marathon runners, skiers and soldiers on subarctic exercises, the pooled relative risk was 0.48 (95% CI 0.35 to 0.64), roughly halving colds (McMaster summary).
  • Shortening colds: across 31 comparisons covering 9,745 episodes, regular daily use had a modest but consistent effect on duration. In children, 1 to 2 g a day shortened colds by 18% (Cochrane abstract). An earlier edition put the reduction at 8% for adults and 13.6% for children (2007 edition). Taking it after symptoms start. Therapeutic trials, where vitamin C began once a cold had begun, did not replicate the benefit. The NIH consumer fact sheet likewise says starting after symptoms appear does not seem helpful. The Cochrane authors still suggested individuals could trial it for themselves, given its low cost and safety.

Reading the evidence fairly. Sources differ in tone: the Mayo Clinic says supplements will not prevent colds and have little effect on length or severity, while the Cochrane authors see a small but consistent duration benefit. Both are compatible with the data. A daily tablet is not a cold shield, but regular users may shave a fraction of a day off an illness, and people under heavy physical stress or with marginal intake may gain more.

Blood pressure and heart health

Blood pressure: a small, consistent drop. Three analyses of randomized trials point the same way, though the effect is modest.

Analysis Scope Systolic change
Juraschek et al., Am J Clin Nutr 2012 29 trials, doses 60 to 4,000 mg a day -3.84 mm Hg (95% CI -5.29 to -2.38)
Same analysis, hypertensive participants Subgroup with high blood pressure -4.85 mm Hg
Guan et al., Medicine 2020 8 trials, 614 adults with essential hypertension, studies of 6 weeks or more -4.77 mm Hg (95% CI -6.46 to -3.08)
Umbrella review, Food & Function 2026 6 meta-analyses covering 17 trials About -3.7 mm Hg

The 2012 authors were careful about what this means. They said additional large, well-designed trials were needed before supplements could be recommended for preventing or treating hypertension, noting that long-term trials powered for clinical endpoints have not shown benefit. A reviewer in Relias Media judged the clinical importance of the drop not compelling. For scale, the lead investigator said blood pressure medicines such as ACE inhibitors or diuretics typically lower pressure by about 10 mm Hg (Natural Products Insider).

Heart attacks and strokes: no proven protection. The strongest test is the Physicians’ Health Study II, a randomized, double-blind, placebo-controlled trial of 14,641 male physicians aged 50 or older. Over a mean of 8 years and 1,245 major cardiovascular events, vitamin C did not reduce risk (JAMA abstract). A Cochrane review of primary prevention reported a hazard ratio of 0.99 (95% CI 0.89 to 1.10) and noted the evidence rested on that one trial of middle-aged and older male physicians in the US.

The NIH fact sheet adds further trials pointing the same way. In the Women’s Antioxidant Cardiovascular Study, 8,171 women with a history of cardiovascular disease took 500 mg a day for a mean of 9.4 years with no overall effect on cardiovascular events (NIH ODS).

Why observational studies look better. Large cohort studies are more encouraging, and the NIH reports that:

  • A pooled analysis of nine cohorts with 293,172 people found 25% lower coronary heart disease in those taking at least 700 mg a day of supplemental vitamin C.
  • In 20,649 British adults, those in the top quarter for blood vitamin C had 42% lower stroke risk than those in the bottom quarter. Such studies cannot separate vitamin C from the healthier diets and lifestyles of the people who have high levels. The NIH also flags a methodological issue: if trial participants were already close to vitamin C saturation, supplements would be expected to change little (NIH ODS).

One caution on combinations. In the Women’s Angiographic Vitamin and Estrogen study, postmenopausal women taking 500 mg of vitamin C plus 400 IU of vitamin E twice daily had higher all-cause mortality than placebo (NIH ODS). That was a combination product in a specific high-risk group, but it is a reason not to assume that more antioxidant means more protection.

Iron absorption

This is one of vitamin C’s best-documented effects, with a catch about how it plays out over time. Iron in plant foods is nonheme iron, which the body absorbs poorly: roughly 2% to 20%, compared with 15% to 35% for heme iron from animal foods (Pharmacy Times). Vitamin C converts it into a form that is easier to absorb.

Single meals. A systematic review and meta-analysis by Heffernan pooled studies using isotopically labelled iron meals in healthy adults. Adding ascorbic acid increased iron absorption by 5.87 percentage points (95% CI 4.43 to 7.31; 315 participants), with very low inconsistency between studies. The author concluded that vitamin C from food or supplements is a practical way to reduce the risk of iron deficiency.

Whole diet. The effect is smaller when measured across everything a person eats. In a study of iron absorption from a complete diet, 12 subjects showed no significant difference in mean absorption across three diet periods, even though daily vitamin C intake ranged from 51 to 247 mg. The facilitating effect was far less pronounced than from single meals, which may explain why long-term supplement trials often show little change in iron status.

What this means in practice.

  • The benefit is largest when vitamin C is taken in the same meal as plant-based iron or an iron supplement.
  • People with low iron stores, vegetarians and vegans are the most likely to notice a difference, though nothing here replaces a blood test and medical advice.
  • Tea, coffee, milk, alcohol and calcium-rich foods can reduce iron absorption, so it helps to keep them apart from iron-rich meals (Pharmacy Times).
  • People with hereditary hemochromatosis should avoid chronic high-dose vitamin C, since it can worsen iron overload (NIH ODS).

Skin and collagen

The biology is solid. Collagen cannot be made properly without vitamin C, which is why scurvy shows up first as fragile blood vessels, bruising and poor wound healing (NIH ODS). A review in Nutrients reports that normal skin holds high concentrations of vitamin C, which supports collagen synthesis and helps protect against UV-induced photodamage. Levels are lower in aged or photodamaged skin. In cell studies, vitamin C increased collagen I and IV production in human skin fibroblasts (review table).

Vitamin C is actively pulled into skin cells by dedicated transporters, which suggests the skin depends on it (Carr and Maggini). The same authors list shorter wound-healing time in patients among its documented effects in their review table.

What a tablet can and cannot do. The Linus Pauling Institute explains that oral supplementation does raise skin vitamin C levels. But once plasma levels are saturated, skin concentrations stop rising, and the optimum skin concentration is not yet known. It also states that effects in skin are not well understood because research is limited.

Anti-aging claims. A review of vitamin C as a cosmeceutical says it is expected to attenuate photoaging by reducing oxidative stress and promoting collagen gene expression. That literature leans heavily on topical use and laboratory data. The sources reviewed here include no large placebo-controlled trial showing that an oral tablet, taken by someone with adequate intake, reduces wrinkles or visibly improves skin.

The honest summary: a daily tablet keeps skin supplied and supports collagen and healing, especially if your diet is low in fruit and vegetables. Beyond that, expect support rather than a cosmetic transformation.

Eye health: macular degeneration and cataracts

Vitamin C is concentrated in the eye, and oxidative stress is thought to contribute to both age-related macular degeneration (AMD) and cataracts. The trial evidence splits cleanly: vitamin C may help slow existing AMD as part of a formula, but there is no sign it prevents either condition. All figures below come from the NIH fact sheet.

Slowing AMD progression. The Age-Related Eye Disease Study (AREDS) tested 500 mg vitamin C with 400 IU vitamin E, 15 mg beta-carotene, 80 mg zinc and 2 mg copper in 3,597 older adults. Among those at high risk (intermediate AMD, or advanced AMD in one eye), the formula lowered the risk of progressing to advanced AMD by 28% over an average of 6.3 years. The follow-up AREDS2 trial confirmed the value of similar formulations.

Preventing AMD. Prospective studies mostly do not support a protective effect, and a 2007 BMJ systematic review concluded the evidence does not support antioxidant supplements for primary prevention of early AMD.

Cataracts: mixed signals.

  • A Japanese cohort of more than 30,000 adults linked higher dietary vitamin C to lower cataract risk.
  • A Swedish cohort of 24,593 women found about 1,000 mg a day of supplemental vitamin C was associated with a 25% higher risk of cataract extraction. Multivitamins with around 60 mg showed no such link.
  • In AREDS, 500 mg of vitamin C with vitamin E and beta-carotene did not significantly lower cataract risk or progression, and AREDS2 agreed. Taken together, a standalone vitamin C tablet has no demonstrated role in protecting the eyes. Anyone with diagnosed intermediate or advanced AMD should ask an eye specialist about an AREDS-type formula rather than assembling one from separate tablets, since the studied combination includes high-dose zinc and other ingredients.

Gout and uric acid

Gout is driven by high blood uric acid, and vitamin C appears to lower it a little. A meta-analysis of randomized trials found that oral vitamin C significantly lowered serum uric acid, with larger reductions in placebo-controlled trials. Examine summarizes the size of the effect as about 0.35 mg/dL.

Does it prevent gout? The best evidence comes from the Physicians’ Health Study II, where 500 mg a day of vitamin C modestly reduced the risk of new gout diagnoses in middle-aged male physicians. The authors called for more research on higher doses and on people who already have gout.

Does it treat gout? Not on its own. A Cochrane review of supplements for chronic gout found one trial comparing vitamin C with the drug allopurinol. Vitamin C lowered uric acid far less (a fall of 0.014 mmol/L versus 0.118 mmol/L), the evidence was low quality, and the effect on gout attacks was not assessed.

A daily tablet may be a reasonable low-risk extra for someone prone to gout, but it does not replace urate-lowering medicine. One counterweight: high vitamin C intakes can increase urinary oxalate and uric acid excretion, which the NIH notes could contribute to kidney stones in some people (see the safety section).

Cancer: prevention and treatment

Cancer is where the gap between hope and evidence is widest. All figures here come from the NIH fact sheet, which also lists the primary trials.

Prevention. Case-control studies find that people with higher dietary vitamin C intake have lower risk of several cancers, and people with cancer tend to have lower blood levels. Prospective cohort results are inconsistent, and most randomized trials find no effect:

  • In the Physicians’ Health Study II, 500 mg of vitamin C (with vitamin E) did not reduce prostate or total cancer over a mean of 8 years.
  • In the Women’s Antioxidant Cardiovascular Study, 500 mg a day for an average of 9.4 years had no significant effect on total cancer incidence or cancer mortality.
  • In SU.VI.MAX, 13,017 French adults took 120 mg of vitamin C with other antioxidants and minerals; total cancer incidence fell in men but not women after 7.5 years. The NIH notes a limitation: if participants were already near vitamin C saturation, supplements would be expected to change little. Fruit and vegetable intake is still linked to lower risk of most cancers, perhaps partly through vitamin C, but a tablet is not equivalent to a diet rich in produce.

Treatment: oral versus intravenous. Oral doses, even very large ones, raise blood levels to a maximum of only 220 micromoles per litre. Intravenous vitamin C can reach concentrations as high as 26,000 micromoles per litre, which are selectively toxic to tumor cells in laboratory studies and have shown promise in mice. In a randomized Mayo Clinic trial, 10 g a day by mouth did no better than placebo in advanced colorectal cancer. Whether high-dose intravenous vitamin C helps patients remains an open research question, not an established therapy.

If you are having cancer treatment. Some data suggest antioxidants might protect tumor cells from radiation and certain chemotherapy drugs, while other data suggest they protect normal tissue. Because the evidence is unresolved, the NIH advises anyone undergoing chemotherapy or radiation to talk to their oncologist before taking vitamin C or other antioxidant supplements, especially in high doses.

Dose, absorption and tablet form

The body regulates vitamin C tightly, so beyond a point extra tablets mostly end up in the toilet. The NIH fact sheet describes a dose-dependent absorption transporter, and the numbers show a clear plateau.

Daily intake What the body does
30 to 180 mg About 70% to 90% is absorbed
100 mg or more Cells appear saturated
200 mg or more Blood levels rise only marginally
Above 1 g Absorption falls below 50%; the rest is excreted in urine
1.25 g Peak blood level of 135 micromoles per litre, about double that from 200 to 300 mg of dietary vitamin C

Even 3 g taken every 4 hours was predicted to peak at only 220 micromoles per litre. Total body content ranges from about 300 mg (near scurvy) to roughly 2 g, with the highest concentrations in white blood cells, eyes, adrenal glands, the pituitary and the brain.

What this means for tablet strength. The trials discussed in this article mostly used 200 mg to 1 g a day: 200 mg or more in the cold trials, 500 mg in the Physicians’ Health Study II, and 250 mg to 1 g in trials of runners and skiers. Higher doses add risk (see safety) without a proven added benefit. A moderate dose is absorbed more efficiently than a very large single one.

Which form. Ascorbic acid is the standard form, with bioavailability equal to that of vitamin C in orange juice or cooked broccoli. Alternatives include sodium or calcium ascorbate, ascorbic acid with bioflavonoids and the branded blend Ester-C. In one study Ester-C gave the same blood levels as plain ascorbic acid but higher white-cell levels 24 hours later; another found no differences among three sources. Given the lower cost, the authors of the latter study concluded that simple ascorbic acid is the preferred source (NIH ODS).

Food still matters. Because absorption plateaus near the amounts food can supply, fruit and vegetables get you most of the way. Cooking destroys some vitamin C, so raw or lightly steamed produce retains more.

Safety: limits, kidney stones and interactions

Australia and US safety guidance differ. Australian and New Zealand Nutrient Reference Values say that available evidence does not allow a formal tolerable upper intake level (UL) to be established for vitamin C, but identify 1,000 mg/day as a prudent adult limit. The US NIH sets a formal adult UL of 2,000 mg/day, including intake from food, beverages and supplements; it also sets lower limits for children and adolescents (1,800 mg/day at 14–18 years, 1,200 mg/day at 9–13 years, 650 mg/day at 4–8 years and 400 mg/day at 1–3 years). These limits are not recommended doses, and higher intakes have not been shown to provide broad additional benefits.

The two values should not be treated as interchangeable: the Australian 1,000 mg value is a prudent guidance limit, whereas the US 2,000 mg value is an established UL. They reflect differences in the evaluation of the evidence, not a biological difference between Australians and Americans. Australian NRVs; NIH ODS.

Common side effects. The usual complaints at high doses are diarrhea, nausea and abdominal cramps, caused by unabsorbed vitamin C drawing water into the gut (NIH ODS).

Kidney stones. This is the most studied risk, and it differs by sex.

  • A prospective analysis of 6,245 incident stones found that supplemental vitamin C of 1,000 mg a day or more was linked to higher stone risk in men (hazard ratio 1.19, 95% CI 1.01 to 1.40), but not in women (Am J Kidney Dis 2016). Vitamin C from food was not associated with stones in either sex.

  • In 23,355 Swedish men, those taking vitamin C supplements were almost twice as likely to develop stones: 3.4% versus 1.8% of non-supplement users. The study could not prove cause, and multivitamin use showed no link (Tufts Nutrition Letter; Reuters via Ahram).

  • The NIH adds that the evidence is conflicting overall; the clearest concern is in people who already have excess urinary oxalate. Who should be careful or ask a clinician first.

  • Anyone with a history of kidney stones, especially men considering doses of 1,000 mg or more

  • People with hereditary hemochromatosis, because vitamin C boosts iron absorption and can worsen iron overload

  • People having chemotherapy or radiation, for the reasons given in the cancer section

  • People taking statins, particularly with niacin: vitamin C combined with other antioxidants may blunt the rise in HDL cholesterol, so providers should monitor lipid levels

  • Anyone about to have medical tests: tell the clinician you take vitamin C, as Mayo advises The NIH also notes an observational finding that postmenopausal women with diabetes who took 300 mg or more of supplemental vitamin C had higher cardiovascular death. It describes the significance as uncertain, because no other epidemiological study has seen it. A few lab studies suggested vitamin C can act as a pro-oxidant, but other work has not confirmed harm at high intakes.

Practical takeaways

The evidence supports targeting a daily tablet rather than taking one by default. This is general information, not medical advice.

The strongest case for supplementation is when intake is inadequate or when it forms part of a specific evidence-based treatment. Examples include:

  • People who smoke or live with smokers, who need more vitamin C and tend to have lower levels
  • People with a narrow diet, little fresh fruit and vegetables, malabsorption, or long-term dialysis
  • People under heavy physical stress or cold exposure, where cold incidence fell in the Cochrane trials
  • People relying on plant-based iron or taking an iron supplement, who may absorb more with vitamin C in the same meal
  • People with intermediate age-related macular degeneration, who should ask an eye specialist whether an AREDS2-type combination is appropriate (not vitamin C alone) The case is weakest for healthy adults already eating several servings of fruit and vegetables a day. For them, a tablet is unlikely to prevent colds, heart disease or cancer, and the main plausible gains are a slightly shorter cold, a small blood pressure effect, and a possible small gout benefit.

If you do take one:

  1. Choose plain ascorbic acid; the research does not show a premium form is better.
  2. Choose a dose that suits the purpose. Some trials used 200 to 500 mg/day, but these research doses are not the daily nutrient requirement; Australia recommends 45 mg/day for most adults and the US recommends 75–90 mg/day.
  3. For cold prevention or duration, note that the small trial benefits were observed with regular supplementation, not when treatment started after symptoms appeared; most people do not need a daily tablet simply to prevent colds.
  4. Take it with an iron-rich plant meal if iron absorption is the goal.
  5. Follow your local safety guidance: Australia identifies 1,000 mg/day as a prudent adult limit (not a formal upper level), while the United States sets an adult upper intake level of 2,000 mg/day. Neither figure is a target dose. Ask for medical advice if you have a history of kidney stones or iron overload.
  6. Tell your doctor or pharmacist, especially if you have a chronic condition, take a statin, or are having cancer treatment. Food remains the best first step: a medium orange (about 70 mg) and half a cup of raw red pepper (about 95 mg) together provide around 165 mg, exceeding the daily recommendations for most healthy adults in both Australia and the US, along with other nutrients that tablets do not provide.

Sources

The Australian and US guidance below was checked against official government sources on 12 October 2026. The broader scientific review retains the original article’s source summaries; many of those studies were consulted through abstracts or secondary summaries rather than full texts, so individual figures should be checked against the original papers before publication.

Reference and overview

  • NIH Office of Dietary Supplements, Vitamin C: Fact Sheet for Health Professionals (updated 31 July 2025)
  • NIH Office of Dietary Supplements, Vitamin C: Fact Sheet for Consumers
  • Mayo Clinic, Vitamin C

Colds and immunity

  • Cochrane review, Vitamin C for preventing and treating the common cold (2013), abstract
  • McMaster Optimal Aging summary of the 2013 Cochrane review
  • Medical News Today, summary of the Cochrane update
  • Cochrane 2007 edition, plain-language summary
  • Carr and Maggini, Vitamin C and Immune Function, Nutrients 2017 and its role-in-immune-defense table

Blood pressure and heart health

  • Juraschek et al., Am J Clin Nutr 2012, as summarized by Relias Media, Natural Products Insider and NutraIngredients
  • Guan et al., Medicine 2020, essential hypertension meta-analysis
  • Umbrella review of vitamin C and blood pressure, Food & Function, issue 6, 2026
  • Sesso et al., Physicians’ Health Study II, JAMA 2008
  • Cochrane review, Vitamin C supplementation for the primary prevention of cardiovascular disease

Iron

  • Heffernan, The Regulation of Dietary Iron Bioavailability by Vitamin C, Proc Nutr Soc 2017
  • Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet
  • Pharmacy Times, Orange juice can aid absorption of iron

Skin

  • Pullar et al., The Roles of Vitamin C in Skin Health, Nutrients 2017
  • Linus Pauling Institute, Vitamin C and skin health
  • Ascorbic acid as a cosmeceutical to increase dermal collagen

Gout

  • Juraschek et al., Effect of oral vitamin C on serum uric acid, meta-analysis
  • Effects of vitamin C on gout risk, Physicians’ Health Study II
  • Cochrane review, Dietary supplements for chronic gout
  • Examine, Do any supplements lower uric acid levels

Kidney stones

  • Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones, Am J Kidney Dis 2016
  • Tufts Health and Nutrition Letter, High-dose vitamin C pills could double kidney-stone risk
  • Reuters via Ahram Online, Vitamin C supplements tied to men’s kidney stones

Official national nutrition recommendations

Medical disclaimer: This article provides general educational information and does not replace individual advice from a doctor, pharmacist or accredited practising dietitian.

Related reading: Daily Vitamins: What the Evidence Shows explores the research behind common vitamin supplements.

Comments

One response to “Daily Vitamin C Tablets: What the Evidence Shows”

  1. […] Also read Tanrub’s Daily Vitamins: What the Evidence Shows and Daily Vitamin C Tablets: What the Evidence Shows. […]

Leave a Reply

Your email address will not be published. Required fields are marked *